org placeholder image

Christine Ivashchenko

Director at Sigilon Therapeutics

  • LinkedIn

Email Email: c****@novonordisk.com

phone noPhone Number: (***)-***-****

map
SIGILON THERAPEUTICS

SIGILON THERAPEUTICS

  • description Description
    Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of dise...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Sigilon Therapeutics Org Chart and Mapping

Employees

Kristen Gray

Associate Scienstist, Diabetes Research

Talia Abbate

Associate Engineer, Biomaterials Process Development

David Berger

Cell Therapy Process Development Technician

Jillian Higgins

Principle Associate Scientist

Lauren Sohn

Senior Associate Scientist

Frequently Asked Questions Regarding Christine Ivashchenko

Answer: Christine Ivashchenko works for Sigilon Therapeutics as Director

Answer: Christine Ivashchenko’s role in Sigilon Therapeutics is Director

Answer: Christine Ivashchenko's email address is c***@gmail.com

Answer: Christine Ivashchenko's business email address is c****@novonordisk.com

Answer: Christine Ivashchenko’s direct phone number is (***)-***-****

Answer: Christine Ivashchenko works in the industry of: Biotechnology

Answer: Christine Ivashchenko works Sigilon Therapeutics located at 100 Binney St, Cambridge, Massachusetts, 02142, United States

Answer: Sigilon Therapeutics's Director is Christine Ivashchenko

Answer: Christine Ivashchenko contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@novonordisk.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access